Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience

被引：0
|
作者：
Takaya Iida
Kenichiro Miura
Hideki Ban
Taro Ando
Yoko Shirai
Sho Ishiwa
Atsutoshi Shiratori
Naoto Kaneko
Tomoo Yabuuchi
Kiyonobu Ishizuka
Masanori Takaiwa
Kazuhide Suyama
Masataka Hisano
Motoshi Hattori
机构：
[1] Tokyo Women’s Medical University,Department of Pediatric Nephrology
[2] Matsuyama Red Cross Hospital,Department of Pediatrics
[3] Fukushima Medical University,Department of Pediatrics
[4] Chiba Children’s Hospital,Department of Nephrology
来源：
Clinical and Experimental Nephrology | 2021年 / 25卷
关键词：
Cytomegalovirus infection; Valganciclovir; Prophylaxis; Pediatric kidney transplantation; Adverse event;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：531 / 536
页数：5
相关论文
共 50 条
  • [1] Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience
    Iida, Takaya
    Miura, Kenichiro
    Ban, Hideki
    Ando, Taro
    Shirai, Yoko
    Ishiwa, Sho
    Shiratori, Atsutoshi
    Kaneko, Naoto
    Yabuuchi, Tomoo
    Ishizuka, Kiyonobu
    Takaiwa, Masanori
    Suyama, Kazuhide
    Hisano, Masataka
    Hattori, Motoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (05) : 531 - 536
  • [2] Individualization of Valganciclovir Prophylaxis for Cytomegalovirus Infection in Pediatric Kidney Transplant Patients
    Zhao, Wei
    Fakhoury, May
    Fila, Marc
    Baudouin, Veronique
    Deschenes, Georges
    Jacqz-Aigrain, Evelyne
    THERAPEUTIC DRUG MONITORING, 2012, 34 (03) : 326 - 330
  • [3] Nocardia infection in kidney transplant recipients: A single-center experience
    Matchett, Caroline
    Djamali, Arjang
    Mandelbrot, Didier
    Saddler, Christopher
    Parajuli, Sandesh
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (06)
  • [4] Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients
    Clark, BS
    Chang, IF
    Karpen, SJ
    Herrera, L
    Scott, JD
    Bristow, LJ
    Quirós-Tejeira, RE
    Goss, JA
    TRANSPLANTATION, 2004, 77 (09) : 1480 - 1480
  • [5] Cytomegalovirus in kidney transplant recipients; Single center experience
    Said, Tarek
    Nampoory, Narayan
    Pacsa, A. S.
    Essa, Sahar
    Madi, Nada
    Prasad, Nair
    Halim, Medhat A.
    Abraham, Mini
    Johny, K. V.
    Samhan, Mahmoud
    Al-Mousawi, Mostafa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 535 - 535
  • [6] Expanded valganciclovir prophylaxis in kidney transplant recipients is associated with lower incidence of cytomegalovirus infection
    Veceric-Haler, Zeljka
    Bizjak, Bostjan
    Romozi, Karmen
    Arnol, Miha
    CLINICAL NEPHROLOGY, 2017, 88 : S126 - S130
  • [7] EXTENDING VALGANCICLOVIR PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS IS ASSOCIATED WITH LOWER INCIDENCE OF CYTOMEGALOVIRUS INFECTION
    Bizjak, Bostjan
    Veceric-Haler, Zeljka
    Romozi, Karmen
    Arnol, Miha
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 407 - 407
  • [8] NOVEL CORONAVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS (A SINGLE-CENTER EXPERIENCE)
    Semenova, Elena
    Vladimirov, Pavel
    Vinokurov, Alexey
    TRANSPLANT INTERNATIONAL, 2021, 34 : 269 - 270
  • [9] Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: A single center experience
    Babel, N
    Gabdrakhmanova, L
    Juergensen, JS
    Eibl, N
    Hoerstrup, J
    Hammer, M
    Rosenberger, C
    Hoeflich, C
    Frei, U
    Rohde, F
    Volk, HD
    Reinke, P
    TRANSPLANTATION, 2004, 78 (02) : 283 - 285
  • [10] Low-dose valganciclovir prophylaxis for cytomegalovirus in intermediate-risk (R plus ) renal transplant recipients: Single-center experience
    Khan, Salman
    Fischman, Clara
    Huprikar, Shirish
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (06)
12345